Protease-Activated Receptors, Apoptosis and Tumor Growth

被引:14
作者
Borensztajn, Keren S. [1 ]
Spek, C. Arnold [1 ]
机构
[1] Univ Amsterdam, Acad Med Ctr, Ctr Expt & Mol Med, NL-1105 AZ Amsterdam, Netherlands
关键词
Apoptosis; Blood coagulation and cancer; Coagulation factors; Protease-activated receptors; Tumor growth;
D O I
10.1159/000175152
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Protease-activated receptors (PARs) are G-protein-coupled receptors (GPCRs) that are activated by a unique proteolytic mechanism. Besides the important role of blood coagulation factors in preventing bleeding after vascular injury, these serine proteinases actively engage target cells thereby fulfilling critical functions in cell biology. Cellular responses triggered by coagulation factor-induced PAR activation suggest that PARs play an important role in proliferation, survival and/or malignant transformation of tumor cells. Indeed, PAR expression correlates with cancer malignancy and clinical studies show that anticoagulant treatment is beneficial in cancer patients. In this review, we provide an overview on the PAR family, their mode of activation and mechanisms by which PAR signaling is terminated. In addition, we discuss the relationship between blood coagulation and cancer biology focusing on the potential role of PAR-induced modulation of cell survival, apoptosis and tumor growth. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:137 / 147
页数:11
相关论文
共 113 条
[1]  
Ahmad R, 2000, INT J CANCER, V87, P707, DOI 10.1002/1097-0215(20000901)87:5<707::AID-IJC13>3.3.CO
[2]  
2-N
[3]   Signaling mechanism in the induction of apoptosis by thrombin in human tumor cells [J].
Ahmad, R ;
Menezes, J ;
Ahmad, A .
BLOOD, 2000, 96 (12) :4001-4001
[4]   Agonists and antagonists of protease activated receptors (PARs) [J].
Barry, GD ;
Le, GT ;
Fairlie, DP .
CURRENT MEDICINAL CHEMISTRY, 2006, 13 (03) :243-265
[5]  
Bates PA, 2001, PROTEINS, P39
[6]  
Bates PA, 1999, PROTEINS, P47
[7]   Effector pathway-dependent relative efficacy at serotonin type 2A and 2C receptors: Evidence for agonist-directed trafficking of receptor stimulus [J].
Berg, KA ;
Maayani, S ;
Goldfarb, J ;
Scaramellini, C ;
Leff, P ;
Clarke, WP .
MOLECULAR PHARMACOLOGY, 1998, 54 (01) :94-104
[8]   Overexpression of protease-activated receptors-1,-2, and-4 (PAR-1,-2, and-4) in prostate cancer [J].
Black, Peter C. ;
Mize, Gregory J. ;
Karlin, Peter ;
Greenberg, Daniel L. ;
Hawley, Sarah J. ;
True, Lawrence D. ;
Vessella, Robert L. ;
Takayama, Thomas K. .
PROSTATE, 2007, 67 (07) :743-756
[9]   PAR1 is a matrix metalloprotease-1 receptor that promotes invasion and tumorigenesis of breast cancer cells [J].
Boire, A ;
Covic, L ;
Agarwal, A ;
Jacques, S ;
Sherifl, S ;
Kuliopulos, A .
CELL, 2005, 120 (03) :303-313
[10]   Coagulation factor Xa drives tumor cells into apoptosis through BH3-only protein Bim up-regulation [J].
Borensztajn, Keren S. ;
Bijlsma, Maarten F. ;
Groot, Angelique P. ;
Bruggemann, Lois W. ;
Versteeg, Henri H. ;
Reitsma, Pieter H. ;
Peppelenbosch, Maikel P. ;
Spek, C. Arnold .
EXPERIMENTAL CELL RESEARCH, 2007, 313 (12) :2622-2633